Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma

Published:2022-09 Issue: Volume:132 Page:105993
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Babu Shyamaladevi,Krishnan Madhan,Priya Veeraraghavan Vishnu,Jayaraman Selvaraj

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference11 articles.

1. MicroRNA expression is associated with human papillomavirus status and prognosis in mucosal head and neck squamous cell carcinomas;Emmett;Oral Oncol,2021

2. Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma;Geidel;NPJ Precis Oncol,2022

3. Comprehensive microRNA-sequencing of exosomes derived from head and neck carcinoma cells in vitro reveals common secretion profiles and potential utility as salivary biomarkers;Langevin;Oncotarget,2017

4. MiRNA expression profiling and emergence of new prognostic signature for oral squamous cell carcinoma;Rajan;Sci Rep,2021

5. Diagnostic Value of Salivary miRNA in Head and Neck Squamous Cell Cancer: Systematic Review and Meta-Analysis;Kang;Int J Mol Sci,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review on Emerging Techniques for Diagnosis of Colorectal Cancer;Cancer Investigation;2024-02-07

2. Association of salivary miRNAs with onset and progression of oral potentially malignant disorders: Searching for noninvasive biomarkers;Journal of Dental Sciences;2023-01

3. Assess the Level of Stress among the Staff Nurse Working in Saveetha Medical College and Hospital during Covid-19 Pandemic;ASEAN J PSYCHIATR;2023

4. Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders – Reply;Oral Oncology;2022-12

5. Salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders;Oral Oncology;2022-11